Cargando…
1611P Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer
Autores principales: | Segelov, E., Body, A., Lal, L., Abdulla, H., Turville, S., Naing, Z., Opat, S., Leahy, M., Balendra, J.R., Hamad, N., Mccuaig, R., Rao, S., Lineburg, K., Smith, C., MacIntyre, C.R., Milch, V., Busija, L., Ahern, E.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472460/ http://dx.doi.org/10.1016/j.annonc.2022.07.1704 |
Ejemplares similares
-
286P Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
por: Body, A., et al.
Publicado: (2022) -
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)
por: Body, Amy, et al.
Publicado: (2022) -
Rapid Protocol Development, Study Startup and Enrolment of a Prospective Study of COVID-19 Vaccination for Patients with Cancer: A Collaborative Approach
por: Body, Amy, et al.
Publicado: (2022) -
Fugitive Sheet Dated 1611
Publicado: (1923) -
The first cataract surgeons in Latin America: 1611–1830
por: Leffler, Christopher T, et al.
Publicado: (2016)